Skip to main content
Download PDF
  • Research article
  • Open access
  • Published:

Coping with the burden of the COVID-19 pandemic: a cross-sectional study of community pharmacists from Serbia

BMC Health Services Research volume 21, Article number: 304 (2021) Cite this article

Abstract

Background

Rapid spread of COVID-19 forced the public to turn to community pharmacies as the most accessible points of primary healthcare, overloading pharmacy services. The objectives of this research were to detect and describe the changes in work environment of community pharmacists in Vojvodina during the state of emergency due to COVID-19 pandemic. Moreover, the COVID-19 pandemic effects on job related stress were assessed.

Methods

Community pharmacists from Vojvodina completed an online questionnaire on work environment changes related to COVID-19 (cross-sectional study).

Results

Out of the 1574 licenced pharmacists in Vojvodina, 392 completed the survey. Workload increase, reported by 90.8% of pharmacists, was caused mostly by higher demand for safety equipment, antiseptics and disinfectants, dietary products and medicines. Most pharmacists (93.1%) considered pharmacy workflow to be more complex than before the pandemic. Clients’ behavior was described as less pleasant since the start of the pandemic by 67.6% of the community pharmacists. Many were concerned for their health and the health of their families (68.9%). Community pharmacists rated their stress levels higher if they i) were working in larger chains, ii) experienced clients’ behavior as less pleasant or/and iii) were concerned for their/their family health.

Conclusions

Current research pointed out the need for a more robust healthcare system which would allow rapid introduction of new activities and roles for community pharmacists that could possibly decrease job-related stress. Legal steps to improve the work environment in community pharmacies are necessary and urgent in order to fully utilize their skills and knowledge.

Peer Review reports

Introduction

Severe acute respiratory syndrome caused by coronavirus 2 (SARS-CoV-2) was first identified in December 2019 in China. The first case of COVID-19 in Serbia was reported on March 6, 2020. On March 11, 2020, the World Healthcare Organization (WHO) declared coronavirus disease (COVID-19) outbreak a global pandemic [1]. WHO called upon the swift action of governments and societies to prepare themselves for the pandemic, bettering their emergency response systems, communicating the risks and educating the public on means of protection. This decision has societal, political and economic consequences that are hard to fully foresee at this moment, but its effect on healthcare systems is already palpable. The pandemic has strained health systems worldwide to their limits [2,3,4] causing the public to turn to community pharmacists as the most accessible primary healthcare providers. Community pharmacies are frequently the first point of contact with the healthcare system with enormous potential to relieve the burden of COVID-19 pandemics for other healthcare providers, allowing them to focus on more severe cases [5]. During these challenging times, the importance of pharmacy personnel as front-line healthcare workers and their potential is starting to be fully recognized by both, the public and the healthcare system. The ongoing transformation of pharmacy from medicine-centered to patient-centered care [6] might be accelerated by the pandemic, but the effects of such rapid changes on pharmaceutical workforce are unclear [7, 8]. Continual threat of infection together with changes in supply chains, workflow and work routines, difficult clients’ behavior, managing crowding and social distancing in pharmacies have been shown to be significant stressors [7, 9] with potential to increase work-related stress [7, 10] of pharmacy teams.

In Serbia, state of emergency that was in effect from March 15 to May 6, 2020, affected many community pharmacies’ activities, from procurement to provision of pharmaceutical care, due to limited movement and imposed curfew. At the moment of submission of this article, there were 271,364 of registered cases of COVID-19 and 2380 death cases in Serbia (mortality ratio 0.88%), according to the official data [11]. However, data on the effect of pandemic on community pharmacists in Serbia are not available.

The aims of this study were to detect and describe the changes in work environment of community pharmacists in the Autonomous Province of VojvodinaFootnote 1 during the state of emergency due to COVID-19 pandemic and to assess the effect of those changes on job-related stress.

Methods

This research was an observational, cross-sectional study, carried out in a sample of 392 pharmacists working in community pharmacies in Vojvodina in April and May 2020, during the state of emergency due to COVID-19 pandemic.

Research instrument

A 36-items questionnaire was developed to assess the changes in work environment of community pharmacists during the COVID-19 pandemic (Additional file 1). Face and content validity of the questionnaire were reviewed by a group of 5 pharmacists: 3 community pharmacists (30, 41 and 65 years old) and 2 academic pharmacists with previous experience in community pharmacies of 5+ years (minimizing questionnaire bias). In response to reviewers’ suggestions, one question was moved to a different section of the questionnaire. Questionnaire was administered online using Google Forms. Online form was tested for practical issues by a group of 9 community pharmacists (7 females, age range 26–61 y), but their feedback did not lead to any changes being made.

The invitation text provided information on study rationale and goals, the concept of anonymity and voluntary nature of participation in the study. A short explanation on data handling and management was given. Research team was introduced and contacts were provided in case of any issues or questions. Potential participants were then asked to confirm they are: 1) pharmacists currently working in community pharmacies in Vojvodina and 2) willing to participate in the study (eligibility criteria). It was clearly stated that answering “yes” was considered as a consent for their participation. Upon confirmation, the participants answered questions on general information, workload, workflow, interactions with clients, work conditions and personal perceptions of different aspects of their job. Skip logic was used to ensure participants get to answer only questions that are relevant to them according to their previous answers.

Sample

According to the data of the Pharmaceutical Chamber of Serbia (PCS), there were 1574 registered pharmacists in Vojvodina licenced for work in community pharmacies at the moment of the study (study population). Using power analysis, the minimum sample size for the said population was determined to be 309 (confidence level 95% (α = 0.05), margin of error 5%).

An invitation e-mail was sent by a representative of the PCS to all 1574 registered community pharmacists from Vojvodina (using the PCS register) in compliance with the current national Law on the Protection of Personal Data. Over a period of 3 weeks, 392 community pharmacists completed the survey (voluntary response sampling, response rate 24.9%).

Statistics

Statistical analysis was performed using SPSS Statistics for Windows, ver. 24 (IBM Corporation).

Categorical variables were characterized using frequencies, while means and standard deviations were used to describe continuous variables. Where appropriate, numerical variables were transformed into categorical for the purpose of interpretation. χ2 test was used to assess differences in categorical variables between groups, followed by post hoc testing using the proportion test. Ordinal regression analysis was used to assess the dependence of the perception of job-related stress (3-point Likert scale; high, moderate, low) on a set of 10 predictor variables (categorical and ordinal).

A p value of < 0.05 was considered statistically significant.

Results

Out of the 1574 eligible pharmacists, 392 community pharmacists were included in the sample. Most of the participants were females, working in community pharmacies that are part of large pharmacy chains and in urban areas (Table 1). High proportion of female pharmacists in the sample corresponds to the proportion of females in the study population (91.1%).

Table 1 General characteristics of community pharmacists in the sample (N = 392)
Full size table

Workload

Most respondents reported an increase in their workload during the COVID-19 pandemic (90.8%) as shown in Table 2. Differences were observed in the proportion of pharmacists reporting the changes in their workload by gender (p = 0.032), age (p = 0.003), years of experience (p = 0.031) and type of pharmacy (p = 0.002). Increase in workload was more often reported by women (p = 0.033), by younger pharmacists (<35y) in comparison to 45+ (p < 0.001), respondents with < 10 years of experience (p = 0.021) and those working in chains of 15+ pharmacies compared to independently owned (p < 0.001) (see Additional file 2).

Table 2 Perception of workload, workflow, interactions with clients and availability of protection equipment during COVID-19 pandemic among community pharmacists in Vojvodina
Full size table

The dominant reasons for the increased workload were (N = 356) higher demand for safety equipment (e.g. gloves, masks) (97.8%), antiseptics and disinfectants (96.9%), dietary products (83.7%) and medicines (62.9%), followed by disinfecting procedures, higher prescription load, counseling and compounding.

Notable increase in demand for analgesics and antipyretics was observed by 94.1% of community pharmacists, for antiseptics by 84.6% pharmacists, anxiolytics, sedatives and hypnotics (49.7%), antimalarials (44.1%), antivirotics (21.9%), antihypertensives (18.8%) and extemporaneous medicines (17.7%) and antibiotics, namely azithromycin. Stocking up on medications for chronic conditions by clients was also reported.

Dietary products/supplements reportedly in high demand were vitamin C (noted by 97.8% of the respondents), zinc (97.8%), multivitamin-multimineral supplements (71.9%), beta-glucans (57.9%), germanium and ganoderma (46.1%), bee product-based supplements (45.8%), as well as echinacea, alkylglycerols, valerian, melatonin, aloa, noni, vitamin D and selenium-containing antioxidant supplements.

Shortages of safety equipment were reported by 98.0% of community pharmacists, of antiseptics and disinfectants by 96.6%, dietary products and medicines by 59.6 and 58.7%, respectively. To overcome the shortages, surveyed community pharmacists reported setting/limiting the number of product units per purchase for clients (85.4%), communicating with suppliers more often (68.3%) and compounding of solutions and gels in 36.5% of the cases.

Workflow

Majority of community pharmacists (93.1%) considered pharmacy workflow to be affected by the COVID-19 pandemic (Table 2). Reporting workflow changes differed by gender (p = 0.028) and job position (p = 0.023). Females claimed that workflow was affected more often than males (p = 0.023), as well as responsible pharmacists when compared to pharmacist in non-managing positions (p = 0.028). New processes were interpreted as more complex than before the pandemic by 61.4% of pharmacists (see Additional file 3).

Interactions with clients

Community pharmacists rated clients’ demeanor during the COVID-19 pandemic mostly as less pleasant than before (67.6%) (Table 2). Those from the < 35 years-group rated clients’ behavior as less pleasant more often than older pharmacists (35–44 and 45+ y) (p = 0.011, p < 0.001, respectively). Respondents with 10+ years of experience observed more pleasant clients’ behavior than pharmacists with < 10 y experience (p = 0.005). Pharmacists working in chains of ≤4 pharmacies rated their clients’ demeanor as pleasant more frequently than those in chains with 5–15 and >15 pharmacies (p = 0.030 and p < 0.001, respectively) (see Additional file 4). One third of surveyed pharmacists (33.7%) noted that clients did not follow the recommended safety measures.

Working conditions

Safety equipment was always available to 48.0% of the participants, while the other 52.0% had experienced occasional shortages (see Table 2 and Additional file 5). Protective equipment was provided completely or partially by the employer to 53.8 and 42.3% of pharmacists, respectively.

One percent of the respondents did not use any safety equipment. Protective masks and gloves were most commonly used (by 95.9 and 95.2% of pharmacists, respectively). Physical barriers were available in pharmacies of 75.5% of respondents.

Job-related personal perceptions of pharmacists

Majority of the respondents were concerned for their/their families’ health (68.9%) during the pandemic. Inaccurate and incomplete reporting about COVID-19 related issues in the media affected the work of 75.0% of surveyed pharmacists. Many noticed the lack of time to devote to patients (72.7%). Most (95.4%) considered physical barriers between pharmacy employees and clients to be necessary.

The possibility of compounding during the pandemic was perceived as an activity that could improve pharmaceutical care by 74.4% of pharmacists. Pharmacists believed they should be authorized to independently renew prescriptions for stable chronic conditions in 46.2% of the cases, while 40.8% were opposed to the idea. The potential role of pharmacists in immunization against COVID-19 was supported by 29.6% of respondents.

Regression model

Ordinal regression model was used to assess the effect of community pharmacists’ characteristics and changes in work environment on job-related stress perception. The model was statistically significant (χ2 = 77.669, p < 0.001) and explained 24.1% of the results variance (Table 3). Community pharmacists working in chains of 5–15 and >15 pharmacies were 3.088 and 2.795 times more likely to rate their job-related stress higher (p = 0.042 and p = 0.043, respectively) in comparison to pharmacist working in independently owned pharmacies. Pharmacists reporting their clients behavior as less pleasant were 2.079 more likely to rate their job-related stress higher (p = 0.029). Pharmacists expressing low concern for their/their families’ health were less likely to report high levels of job-related stress during the pandemic (OR = 0.157, p < 0.001).

Table 3 Ordinal regression model: Odds ratios (OR) and 95% confidence intervals (CI) for the association of community pharmacists’ characteristics and changes in work environment with job-related stress perception
Full size table

Discussion

Our study detected significant changes in work environment of community pharmacists in Vojvodina at the times of COVID-19 pandemic.

Workload

During the COVID-19 pandemic, community pharmacists’ workload has drastically increased worldwide [9, 12,13,14,15]. Our respondents’ workload increased mainly by the surge in demand for specific pharmaceutical products. Increase in workload has affected females, younger, less experienced and pharmacists in larger chains more severely. Females’ perception might have been intensified by the higher burden of domestic work, unpaid care for children and older family members during the pandemic [16]. Many pharmacies engaged older employees in administrative tasks, perceived as more safe and resilient [9]. Such reorganization left the younger and the less experienced pharmacists at the counter, dealing with clients, possibly causing them to notice the increase in workload more. Larger workload in bigger chains was previously observed by researchers [17, 18].

Information on COVID-19 infection management presented by the health authorities, the researchers and the media [19,20,21] caused high demand for specific medicines. The observed surge in demand for anxiolytics, sedatives and hypnotics implies the possible negative effect of the pandemic (and/or mechanisms to fight it) on mental health of our population – an indirect effect of COVID-19 [22].

Dietary supplements with claimed immunomodulatory or antiviral effect were the most sought-after, similar to other countries [23]. Bee product-based supplements were in high demand, as they are traditionally highly valued and more often used [24] in the region.

Shortages of safety equipment, disinfectants, antiseptics, medicines and dietary products are a global problem [25,26,27,28]. All of our subjects have noticed shortages of the aforementioned products. Clients’ stocking up on chronic medication, possibly out of fear and uncertainty [13, 15, 29], present an added strain on the healthcare system. In attempts to overcome shortages, community pharmacists in Vojvodina resorted most often to limiting the number of products per purchase, as suggested by WHO [30] and sourcing from multiple suppliers, as pharmacists in other countries [21]. Only one third of surveyed pharmacists started compounding solutions and gels, although it has been recommended by WHO [30], possibly due to shortage of alcohol and other disinfecting substances and compounding-related legal limitations. Several European countries made legal changes to allow for compounding at pharmacies with no registered compounding services to mitigate the shortages [31]. Reluctance of pharmacists to start compounding might be linked to the lack of knowledge, confidence or instructions for preparation [29]. As compounding is a specific pharmacists’ skill, community pharmacists should be encouraged to compound deficient products and adopt more proactive attitudes towards compounding [29].

Workflow

Changes in workflow noticed by surveyed pharmacists were mostly administrative and procurement-related. Although changes were introduced to simplify pharmacists’ work during the pandemic, most pharmacists found them more complex and many shared negative thoughts and experiences with the new processes. Job-related changes are associated with feelings of anxiety, resistance [32], insecurity, loss of control and general inconvenience [33]. Employee training and education could be helpful strategies in increasing employees’ adaptability [32], but during the pandemic, these were not possible.

Interactions with clients

The usual pharmacist-client interactions were strained during the pandemic due to clients’ amplified emotional responses – fear, anxiety, panic-buying and/or non-conforming to preventive measures [9, 15, 34], as reported by two thirds of surveyed pharmacists. Younger pharmacists rated clients’ behavior as less pleasant more frequently, possibly because older pharmacist had limited interactions with clients. Pharmacists from bigger organizations reported clients’ behavior being less pleasant during the pandemic in comparison to those from smaller chains. This could stem from higher general satisfaction of clients/patients with independent pharmacies in comparison to chain pharmacies [35].

Working conditions

Recommendations on the use of personal protective equipment (PPE) varied considerably across countries [27]. Almost all of our respondents used masks and gloves, although national recommendations on general protective measures in community pharmacies were published after the data acquisition for this research has been finished (requiring distancing and mask use at all times) [36]. Globally, due to supply problems, personal protective equipment was not always available to pharmacists [34, 37, 38]. In our study, community pharmacists experienced occasional shortages of safety equipment.

Job-related personal perceptions of pharmacists

Pharmacists across the world were highly concerned for their/their families’ health [34, 39,40,41], similar to pharmacists enrolled in our study. Many surveyed pharmacists reported their work to be negatively affected by misinformation on COVID-19 circulated by the media. In an unprecedented “infodemic”, inaccurate and incomplete information about coronavirus spread rapidly adding to the fear and the anxiety of the public [39, 42, 43]. Most of respondents reported not having enough time to devote to clients, but such lack of time was observed even in non-pandemic circumstances [44].

Worldwide PPE shortages pressured many pharmacies to install physical barriers in order to reduce the risk of coronavirus infection of pharmacy teams and clients [15]. Majority of the respondents believed such barriers are necessary. After community pharmacists’ plea, PCS appealed to the National Ministry of Health to make physical barriers mandatory [45].

Dispensing of repeat prescriptions by community pharmacists could relieve some of the burden off the other healthcare workers [13]. Due to pandemic, some countries have already allowed community pharmacists to renew chronic treatment prescriptions [31]. In Serbia, chronic treatment prescription (eTherapy) validity period was extended from 6 to 9 months. Patients had to request the extension from their GPs, leaving the expertise of community pharmacists underutilized. Half of our respondents believed community pharmacists should be authorized to extend eTherapy during the pandemic without consulting patients’ GP. Many opposed that idea, suggesting they do not recognize their potential in chronic patients’ care.

Community pharmacists present a great potential in increasing the number of administered doses of vaccines and reducing the time to achieve high coverage [46]. Active participation of pharmacists in vaccination is not foreseen by relevant legislation in Serbia, which might explain the low percentage of pharmacist with positive attitudes towards active participation in vaccination.

Regression model

Community pharmacists in Vojvodina rated their job-related stress higher if they worked in larger pharmacy chains, if they believed their clients behavior was less pleasant than before the pandemic and if they were more concerned for their/their families’ health. Pharmacists working in larger chains have been shown to be under more stress, mainly due to high prescription volumes, time constraints, overtime etc. [47]. Clients’ inappropriate behavior and concern for their own/family members’ health has also been shown to cause stress and reduce resiliency in pharmacy settings [9, 48,49,50]. In addition, our research was carried out at the beginning of the pandemic, while protective equipment supply was unstable and vaccines were not available, which might explain the contribution of fear of contracting the coronavirus and infecting family members to pharmacists’ stress levels.

Study limitations and strengths

Main advantage of the presented research is a unique perspective on the changes in work environment of community pharmacies in the state of emergency during COVID-19 pandemic. Direct feedback from surveyed pharmacists provided invaluable insight into genuine thoughts regarding the pharmaceutical care provided by community pharmacists during the pandemic.

Due to rapidly changing circumstances, our research used a non-standardized questionnaire. Our results have limited generalizability, due to sampling method, as well as specific regional demographic and social characteristics. All limitations of the cross-sectional study design, as well as positive and negative aspects of online surveying apply to our study (more honest answers, fast, cheap, easy to use for participants and researchers vs. lower response rates, non-response bias).

To the best of authors’ knowledge, this is the first study of this kind conducted in Serbia.

Conclusion

The global COVID-19 pandemic increased the workload and altered the workflow of community pharmacists in Vojvodina. Pharmacists working in larger chains, reporting clients’ behavior as less pleasant and those who were more concerned for their/their families’ health during the pandemic reported higher levels of job-related stress.

Presented findings highlight the opportunity for pharmacists to be recognized as healthcare providers on the frontline of the healthcare system. Current research pointed out the need for more robust healthcare system which would allow rapid introduction of new activities/roles for community pharmacists in order to fully utilize their skills and knowledge. Legal steps to improve the work environment in community pharmacies and better definition of community pharmacists’ role in the healthcare system are necessary and urgent.

Availability of data and materials

Data are available from the corresponding author on a reasonable request.

Notes

  1. The Autonomous Province of Vojvodina is located in the north of Serbia with the population of close to 2 million according to the 2011 Census (28% of the population of Serbia) and covering 25% of the area of Serbia.

Abbreviations

WHO:

World Health Organization

COVID-19:

Coronavirus disease

PCS:

Pharmaceutical Chamber of Serbia

SPSS:

Statistical Package for Social Sciences

References

  1. WHO. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020. 2020 [cited 2020 Jun 24]. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19%2D%2D-11-march-2020

  2. Adams JG, Walls RM. Supporting the health care workforce during the COVID-19 global epidemic. JAMA. 2020;323(15):1439–40. https://doi.org/10.1001/jama.2020.3972.

    Article  CAS  PubMed  Google Scholar 

  3. Legido-Quigley H, Asgari N, Teo YY, Leung GM, Oshitani H, Fukuda K, et al. Are high-performing health systems resilient against the COVID-19 epidemic? Lancet. 2020;395(10227):848–50. https://doi.org/10.1016/S0140-6736(20)30551-1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Verelst F, Kuylen E, Beutels P. Indications for healthcare surge capacity in European countries facing an exponential increase in coronavirus disease (COVID-19) cases, march 2020. Eurosurveillance. 2020;25(13):1–4.

    Article  Google Scholar 

  5. World Health Professions Alliance. World health professionals calling governments to prioritise support for healthcare workers in the front line against coronavirus. 2020 [cited 2020 Jun 24]. Available from: https://www.whpa.org/news-resources/statements/world-health-professionals-calling-governments-prioritise-support

    Google Scholar 

  6. Rosenthal MM, Breault RR, Austin Z, Tsuyuki RT. Pharmacists’ self-perception of their professional role: insights into community pharmacy culture. J Am Pharm Assoc. 2011;51(3):363–7. https://doi.org/10.1331/JAPhA.2011.10034.

    Article  Google Scholar 

  7. Hayden JC, Parkin R. The challenges of COVID-19 for community pharmacists and opportunities for the future. Ir J Psychol Med. 2020;37(3):198–203. https://doi.org/10.1017/ipm.2020.52.

    Article  CAS  PubMed  Google Scholar 

  8. Visacri M, Figueiredo I, de Lima T. Role of pharmacist during the COVID-19 pandemic : a scoping review. Res Soc Adm Pharm. 2021;17(1):1799–806. https://doi.org/10.1016/j.sapharm.2020.07.003.

    Article  Google Scholar 

  9. Austin Z, Gregory P. Resilience in the time of pandemic: the experience of community pharmacists during COVID-19. Res Soc Adm Pharm. 2021;17(1):1867–75. https://doi.org/10.1016/j.sapharm.2020.05.027.

    Article  Google Scholar 

  10. McNicholas F, Sharma S, Oconnor C, Barrett E. Burnout in consultants in child and adolescent mental health services (CAMHS) in Ireland: a cross-sectional study. BMJ Open. 2020;10(1):1–9.

    Article  Google Scholar 

  11. Ministry of Health of the Republic of Serbia. Coronavirus. 2020 [cited 2020 Dec 14]. Available from: https://covid19.rs

    Google Scholar 

  12. Liu S, Luo P, Tang M, Hu Q, Polidoro JP, Sun S, et al. Providing pharmacy services during the coronavirus pandemic. Int J Clin Pharm. 2020;42(2):299–304. https://doi.org/10.1007/s11096-020-01017-0.

    Article  CAS  PubMed  Google Scholar 

  13. Cadogan CA, Hughes CM. On the frontline against COVID-19: community pharmacists’ contribution during a public health crisis. Res Soc Adm Pharm. 2021;17(1):2032–5. https://doi.org/10.1016/j.sapharm.2020.03.015.

    Article  Google Scholar 

  14. Hedima EW, Adeyemi MS, Ikunaiye NY. Community pharmacists: on the frontline of health service against COVID-19 in LMICs. Res Soc Adm Pharm. 2021;17(1):1964–6. https://doi.org/10.1016/j.sapharm.2020.04.013.

    Article  Google Scholar 

  15. Parkhurst C, Singh Purewal G, Donyai P. Community pharmacy and COVID-19—the unsung heroes on our high streets. J Patient Exp. 2020;7(3):282–4. https://doi.org/10.1177/2374373520927638.

    Article  PubMed  PubMed Central  Google Scholar 

  16. United Nations. Policy brief: the impact of COVID-19 on women [Internet]. United Nations; 2020. [cited 2020 Jun 20]. Available from: https://asiapacific.unwomen.org/-/media/headquarters/attachments/sections/library/publications/2020/policy-brief-the-impact-of-covid-19-on-women-en.pdf?la=en&vs=1406.

  17. Kreling DH, Doucette WR, Mott DA, Gaither CA, Pedersen CA, Schommer JC. Community pharmacists’ work environments: evidence from the 2004 National Pharmacist Workforce Study. J Am Pharm Assoc. 2006;46(3):331–9. https://doi.org/10.1331/154434506777069651.

    Article  Google Scholar 

  18. Jacobs S, Ashcroft D, Hassell K. Culture in community pharmacy organisations: what can we glean from the literature? J Health Organ Manag. 2011;25(4):420–54. https://doi.org/10.1108/14777261111155047.

    Article  PubMed  Google Scholar 

  19. Gautret P, Lagier J-C, Parola P, Hoang VT, Meddeb L, Mailhe M, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020;56(1):105949. https://doi.org/10.1016/j.ijantimicag.2020.105949.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. WHO. Clinical management of COVID-19. Interim guidance, 27 May 2020. 2020.

    Google Scholar 

  21. Andalo D. “Unprecedented demand” for OTC painkillers as COVID-19 outbreak spreads. Pharm J. 2020. https://doi.org/10.1211/PJ.2020.20207830.

  22. Pfefferbaum B, North C. Mental health and the Covid-19 pandemic. N Engl J Med. 2020;383(6):510–2. https://doi.org/10.1056/NEJMp2008017.

    Article  CAS  PubMed  Google Scholar 

  23. Adams KK, Baker WL, Sobieraj DM. Myth busters: dietary supplements and COVID-19. Ann Pharmacother. 2020;54(8):820–6. https://doi.org/10.1177/1060028020928052.

    Article  CAS  PubMed  Google Scholar 

  24. Jovičić-Bata J, Grujičić M, Novaković B, Čović B. Epidemiology of dietary supplement use in Serbia: report from Novi Sad. Complement Ther Med. 2019;47:102228. https://doi.org/10.1016/j.ctim.2019.102228.

    Article  PubMed  Google Scholar 

  25. Choo EK, Rajkumar SV. Medication shortages during the COVID-19 crisis: what we must do. Mayo Clin Proc. 2020;95(6):1112–5. https://doi.org/10.1016/j.mayocp.2020.04.001.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Liang WH, Huang J, CJP Z, He Z, Ming WK. Facemask shortage and the novel coronavirus disease (COVID-19) outbreak: Reflections on public health measures. EClinicalMedicine. 2020;21:100329.

    Article  Google Scholar 

  27. Hasan SS, Kow CS, Zaidi STR. Social distancing and the use of PPE by community pharmacy personnel: does evidence support these measures? Res Soc Adm Pharm. 2021;17(2):456–9. https://doi.org/10.1016/j.sapharm.2020.04.033.

    Article  Google Scholar 

  28. Smith C. The structural vulnerability of healthcare workers during COVID-19: observations on the social context of risk and the equitable distribution of resources. Soc Sci Med. 2020;258:113119. https://doi.org/10.1016/j.socscimed.2020.113119.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Ung COL. Community pharmacist in public health emergencies: quick to action against the coronavirus 2019-nCoV outbreak. Res Soc Adm Pharm. 2020;16(4):583–6. https://doi.org/10.1016/j.sapharm.2020.02.003.

    Article  Google Scholar 

  30. WHO Regional Office for Europe. Strengthening the health systems response to COVID-19: community pharmacy [Internet]. Copenhagen; 2020. [cited 2020 Jun 21]. Available from: https://apps.who.int/iris/bitstream/handle/10665/332572/WHO-EURO-2020-677-40412-54174-eng.pdf.

  31. Merks P, Jakubowska M, Drelich E, Świeczkowski D, Bogusz J, Bilmin K, et al. The legal extension of the role of pharmacists in light of the COVID-19 global pandemic. Res Soc Adm Pharm. 2021;17(1):1807–12. https://doi.org/10.1016/j.sapharm.2020.05.033.

    Article  Google Scholar 

  32. Bresciani M, Griffiths J, Rust J. Assessment at North Carolina State University: adapting to change in the workplace. In: Research & Practice in Assessment; 2009. p. 4–12.

    Google Scholar 

  33. Yeatts DE, Edward Folts W, Knapp J. Older workers’ adaptation to a changing workplace: employment issues for the 21st century. Educ Gerontol. 2000;26(6):565–82.

    Article  Google Scholar 

  34. Scott J. COVID-19 and the role of pharmacists and their teams. 2020 [cited 2020 Jun 21]. Available from: http://blogs.bath.ac.uk/iprblog/2020/04/27/covid-19-and-the-role-of-pharmacists-and-their-teams/

    Google Scholar 

  35. Briesacher B, Corey R. Patient satisfaction with pharmaceutical services at independent and chain pharmacies. Am J Heal Pharm. 1997;54(5):531–6. https://doi.org/10.1093/ajhp/54.5.531.

    Article  CAS  Google Scholar 

  36. Institute for Public Health of Serbia. General prevention measures for pharmacies. [Opšte mere prevencije za apoteke.]. 2020.

    Google Scholar 

  37. Livingston E, Desai A, Berkwits M. Sourcing personal protective equipment during the COVID-19 pandemic. JAMA. 2020;323(19):1912–4. https://doi.org/10.1001/jama.2020.5317.

    Article  CAS  PubMed  Google Scholar 

  38. Panthy L, Panthi J, Amgain K, Thapaliya P, Van Laar J. COVID-19 in Nepal: scarcity of personal protective equipment (PPE) and its alternative. Eur J Med Sci. 2020;2(1):74–80.

    Google Scholar 

  39. Karasneh R, Al-Azzam S, Muflih S, Soudah O, Hawamdeh S, Khader Y. Media’s effect on shaping knowledge, awareness risk perceptions and communication practices of pandemic COVID-19 among pharmacists. Res Soc Adm Pharm. 2021;17(1):1897–902. https://doi.org/10.1016/j.sapharm.2020.04.027.

    Article  Google Scholar 

  40. Mhango M, Dzobo M, Chitungo I, Dzinamarira T. COVID-19 risk factors among health workers: a rapid review. Saf Health Work. 2020;11(3):262–5. https://doi.org/10.1016/j.shaw.2020.06.001.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Maaravi Y, Heller B. Not all worries were created equal: the case of COVID-19 anxiety. Public Health. 2020;185:243–5. https://doi.org/10.1016/j.puhe.2020.06.032.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Orso D, Federici N, Copetti R, Vetrugno L, Bove T. Infodemic and the spread of fake news in the COVID-19-era. Eur J Emerg Med. 2020;27(5):327–8. https://doi.org/10.1097/MEJ.0000000000000713.

    Article  PubMed  Google Scholar 

  43. O’Connor C, Murphy M. Going viral: doctors must tackle fake news in the covid-19 pandemic. BMJ. 2020;369:m1587.

    Article  Google Scholar 

  44. Tsao NW, Salmasi S, Li K, Nakagawa B, Lynd LD, Marra CA. Pharmacists’ perceptions of their working conditions and the factors influencing this: results from 5 Canadian provinces. Can Pharm J. 2020;153(3):161–9. https://doi.org/10.1177/1715163520915230.

    Article  Google Scholar 

  45. Pharmaceutical Chamber of Serbia. COVID-19. 2020 [cited 2020 Jun 20]. Available from: https://www.farmkom.rs

    Google Scholar 

  46. Schwerzmann J, Graitcer SB, Jester B, Krahl D, Jernigan D, Bridges CB, et al. Evaluating the impact of pharmacies on pandemic influenza vaccine administration. Disaster Med Public Health Prep. 2017;11(5):587–93. https://doi.org/10.1017/dmp.2017.1.

    Article  PubMed  Google Scholar 

  47. Jacobs S, Hassell K, Ashcroft D, Johnson S, O'Connor E. Workplace stress in community pharmacies in England: associations with individual, organizational and job characteristics. J Health Serv Res Policy. 2014;19(1):27–33. https://doi.org/10.1177/1355819613500043.

    Article  PubMed  Google Scholar 

  48. Calgan Z, Aslan D, Yegenoglu S. Community pharmacists' burnout levels and related factors: an example from Turkey. Int J Clin Pharm. 2011;33(1):92–100. https://doi.org/10.1007/s11096-010-9461-2.

    Article  PubMed  Google Scholar 

  49. Zeenny RM, Ramia E, Akiki Y, Hallit S, Salameh P. Assessing knowledge, attitude, practice, and preparedness of hospital pharmacists in Lebanon towards COVID-19 pandemic: a cross-sectional study. J Pharm Policy Pract. 2020;13:54.

    Article  Google Scholar 

  50. Uebbing E, Lacroix M, Bratberg J, Federico C. Pharmacists’ response during a pandemic: a survey on readiness to test during COVID-19. JAPhA. 2020;61(2):e80–4. https://doi.org/10.1016/j.japh.2020.10.003.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to thank the Pharmaceutical Chamber of Serbia, especially the management of the regional office for Vojvodina for their help with the dissemination of the questionnaire to their members.

The authors express their gratitude to each community pharmacist who took the time to participate in our research.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

  1. University of Novi Sad, Faculty of Medicine, Department of Pharmacy, Hajduk Veljkova 3, Novi Sad, Serbia

    Jelena Jovičić-Bata, Nebojša Pavlović, Nataša Milošević, Neda Gavarić, Svetlana Goločorbin-Kon, Nemanja Todorović & Mladena Lalić-Popović

  2. University of Novi Sad, Faculty of Medicine, Center for Medical-Pharmaceutical Research and Quality Control, Hajduk Veljkova 3, Novi Sad, Serbia

    Neda Gavarić & Mladena Lalić-Popović

Authors
  1. Jelena Jovičić-Bata
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nebojša Pavlović
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nataša Milošević
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Neda Gavarić
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Svetlana Goločorbin-Kon
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Nemanja Todorović
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mladena Lalić-Popović
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors (JJB, NP, NM, NG, SGK, NT, MLP) participated in the planning and conception of the study. JJB, NP, NM, NT and MLP were responsible for data collection and analysis. All authors (JJB, NP, NM, NG, SGK, NT, MLP) participated in data interpretation. JJB and MLP drafted the manuscript. All authors critically revised the original draft and approved the revised manuscript.

Corresponding author

Correspondence to Jelena Jovičić-Bata.

Ethics declarations

Ethics approval and consent to participate

The Ethical Committee of the Faculty of Medicine of the University of Novi Sad waived the need for ethics approval and the need to obtain consent for the collection, analysis and publication of the obtained and anonymized data for this study (April 2020).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jovičić-Bata, J., Pavlović, N., Milošević, N. et al. Coping with the burden of the COVID-19 pandemic: a cross-sectional study of community pharmacists from Serbia. BMC Health Serv Res 21, 304 (2021). https://doi.org/10.1186/s12913-021-06327-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12913-021-06327-1

Keywords

BMC Health Services Research

ISSN: 1472-6963

Contact us